Continuous monitoring of trends in pathogen and susceptibility profiles in patients with skin and soft tissue infections (SSTIs)
Publisher
Walter de Gruyter GmbH
Reference9 articles.
1. Moffarah AS, Al Mohajer M, Hurwitz BL, Armstrong DG. Skin and soft tissue infections. Microbiol Spectr. 2016; 4. doi: 10.1128/microbiolspec.DMIH2-0014-2015
2. McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Microbiol Spectr. 2018; 6. doi: 10.1128/microbiolspec.ARBA-0009-2017
3. Ohnishi T, Watanabe S, Matsumoto T, Yotsuyanagi H, Sato J, Kobayashi I, et al. The second nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2023; 29:143–9. doi: 10.1016/j.jiac.2022.10.005
4. Burnham JP, Kollef MH. Treatment of severe skin and soft tissue infections: a review. Curr Opin Infect Dis. 2018; 31:113–9. doi: 10.1097/QCO.0000000000000431
5. Rath E, Skrede S, Oppegaard O, Bruun T. Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infect Dis (Lond). 2020; 52:361–71. doi: 10.1080/23744235.2020.1726447